News Release 2018 September 21, 2018 Kyorin Receives Marketing Approval in Japan for｢Beova Tablets 50mg｣ for the Treatment of Overactive Bladder May 10, 2018 MSD and Kyorin Sign Agreement to Acquires Exclusive Distribution Rights for Therapeutic Agent for Allergic Rhinitis, NASONEX® Nasal March 29, 2018 Kyorin Pharmaceutical Sign a License Agreement for "SK-1404," a Therapeutic Agent for Nocturia Due to Nocturnal Polyuria 1
